NCT01340131

CKD-828 (40/5mg) Pharmacokinetic Study

Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics of Telmisatan 40mg and S-Amlodipine 5mg as a Fixed Dose Combination Tablet Compared With Combination Therapy in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 68 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics of CKD-828 (Fixed Dose Combination Tablet; Telmisartan and S-Amlodipine) in healthy volunteer.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-828	Drug: Telmisartan 40mg + S-Amlodipine 5mg(FDC) Tablet, Oral, Once Daily
DRUG	Combination Therapy	Drug: Telmisartan 40mg Tablet, Oral, Once Daily Drug: S-amlodipine 5mg Tablet, Oral, Once Daily

Timeline

• Start date: 2011-01-01
• Primary completion: 2011-03-01
• Completion: 2011-04-01
• First posted: 2011-04-22
• Last updated: 2011-04-28

Locations

1 site across 1 country: South Korea